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Abstract
Background: Recently there has been increased interest in pancreatic cholesterol esterase due
to correlation between enzymatic activity in vivo and absorption of dietary cholesterol.
Cholesterol esterase plays a role in digestive lipid absorption in the upper intestinal tract, though
its role in cholesterol absorption in particular is controversial. Serine lipases, acetylcholinesterase,
butyrylcholinesterase, and cholesterol esterase belong to a large family of proteins called the α/β-
hydrolase fold, and they share the same catalytic machinery as serine proteases in that they have
an active site serine residue which, with a histidine and an aspartic or glutamic acid, forms a catalytic
triad. The aim of this work is to study the stereoselectivity of the acyl chain binding site of the
enzyme for four diastereomers of an inhibitor.
Results:  Four diastereomers of 2'-N-α-methylbenzylcarbamyl-1, 1'-bi-2-naphthol (1) are
synthesized from the condensation of R-(+)- or S-(-)-1, 1'-bi-2-naphthanol with R-(+)- or S-(-)-α-
methylbenzyl isocyanate in the presence of a catalytic amount of pyridine in CH2Cl2. The [α]25
D
values for (1R, αR)-1, (1R, αS)-1, (1S, αR)-1, and (1S, αS)-1  are +40, +21, -21, and -41°,
respectively. All four diastereomers of inhibitors are characterized as pseudo substrate inhibitors
of pancreatic cholesterol esterase. Values of the inhibition constant (Ki), the carbamylation constant
(k2), and the bimolecular rate constant (ki) for these four diastereomeric inhibitors are investigated.
The inhibitory potencies for these four diastereomers are in the descending order of (1R, αR)-1,
(1R, αS)-1, (1S, αR)-1, and (1S, αS)-1. The k2 values for these four diastereomers are about the
same. The enzyme stereoselectivity for the 1, 1'-bi-2-naphthyl moiety of the inhibitors (R > S, ca.
10 times) is the same as that for 2'-N-butylcarbamyl-1, 1'-bi-2-naphthol (2). The enzyme
stereoselectivity for the α-methylbenzylcarbamyl moiety of the inhibitors is also R > S (2–3 times)
due to the constraints in the acyl binding site.
Conclusion: We are the first to report that the acyl chain binding site of cholesterol esterase
shows stereoselectivity for the four diastereomers of 1.
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Background
Recently there has been increased interest in pancreatic
cholesterol esterase (CEase, EC 3.1.1.13) due to correla-
tion between enzymatic activity in vivo and absorption of
dietary cholesterol [1,2]. Physiological substrates include
cholesteryl esters, retinyl esters, triacylglycerols, vitamin
esters, and phospholipids [3-5]. CEase plays a role in
digestive lipid absorption in the upper intestinal tract,
though its role in cholesterol absorption in particular is
controversial [1,6]. A recent report indicates that CEase is
directly involved in lipoprotein metabolism, in that the
enzyme catalyzes the conversion of large LDL to smaller,
denser, more cholesteryl ester-rich lipoproteins, and that
the enzyme may regulate serum cholesterol levels [7,8].
Serine lipases, acetylcholinesterase, butyrylcholinesterase,
and CEase belong to a large family of proteins called the
α/β-hydrolase fold [9,10], and they share the same cata-
lytic machinery as serine proteases in that they have an
active site serine residue which, with a histidine and an
aspartic or glutamic acid, forms a catalytic triad [11,12].
The conservation of this catalytic triad suggests that as well
as sharing a common mechanism for substrate hydrolysis,
that is, formation of a discrete acyl enzyme species via the
active site serine hydroxy group, serine proteases, CEase,
and lipases may well be expected to be inhibited by the
same classes of mechanism-based inhibitors such as phos-
phorothiolates [13], pyrones [14], fluoroketones [15],
boronic acids [16], and carbamates [16-29].
The crystal structure of the active site region of pancreatic
CEase [30,31] is similar to Torpedo californica acetylcho-
linesterase (AChE) [32], Candida rugosa lipase (CRL)
[33,34], Geotrichum candidum lipase (GCL) [35], and Pseu-
domonas species lipase (PSL) [36,37]. Moreover, the active
site of CEase like CRL, GCL, PSL, and acetylcholinesterase
may consist of at least five major binding sites (Figure 1)
[23,24,30,31]: (a) an acyl chain binding site (ABS) that
binds to the acyl chain of the substrate and is opened by
the removal of C-terminal 574–579 in which is bent in
shape and contains a deep, wide hole from the evacuation
of Phe579, (b) an oxyanion hole (OAH), the H-bonding
peptide NH functions of Gly107, Ala108, and Ala195,
that stabilizes the tetrahedral species, (c) an esteratic site
or the catalytic triad (ES), comprised of Ser194-His435-
Asp320, that is involved in nucleophilic attack to the sub-
strate carbonyl group and in general acid-base catalysis,
and (d) a leaving group binding site (LBS) or/and the sec-
ond alkyl chain or group binding site (SACS) that binds to
the cholesterol part of cholesterol ester or the second fatty
acid chain of triacylglycerol and is located at the opposite
direction of ABS.
Previous work has shown that CEase is stereoselectively
inhibited by the two atropisomers (or enantiomers) of 1,
1-bi-2-naphtyl carbamates due to the stereoselective bind-
ing at LBS of the enzyme [20,22]. Doorn et al. have also
reported that CEase is stereoselectively inhibited by the
four diastereomers of isomalathion due to stereoselectiv-
ity for both ES and LBS of the enzyme [13]. The aim of this
study is to extend the stereoselectivity to the four diastere-
omers of inhibitors by adding two extra bonds between a
chiral center and (or a chiral axis of the inhibitors. In other
words, we may probe the double selectivity for both ABS
and LBS of the enzyme. Thus, four diastereomers of 2'-N-
α-methylbenzylcarbamyl-1, 1'-bi-2-naphthol (1), 2'-N-
(R)-α-methylbenzylcarbamyl-(R)-1, 1'-bi-2-naphthol
((1R, αR)-1), 2'-N-(S)-α-methylbenzylcarbamyl-(R)-1, 1'-
bi-2-naphthol ((1R, αS)-1), 2'-N-(R)-α-methylbenzylcar-
bamyl-(S)-1, 1'-bi-2-naphthol ((1S, αR)-1), and 2'-N-(S)-
α-methylbenzylcarbamyl-(S)-1, 1'-bi-2-naphthol ((1S,
αS)-1) (Figure 2), are synthesized from condensation of
(R)- or (S)-1, 1'-bi-2-naphthol with (R)-or (S)-α-methyl-
benzyl isocyanate in the presence of pyridine in dichlo-
romethane. The stereoselectivity of CEase inhibition by
the four diastereomers of 1 is evaluated kinetically.
Most carbamate inhibitors are characterized as the pseudo
substrate inhibitors of CEase (Figure 3) [16-29] and meet
some of the criteria proposed by Abeles and Maycock
[38]. First, the inhibition is time-dependent and follows
pseudo-first-order kinetics; second, with increasing con-
centration of inhibitor the enzyme displays saturation
kinetics; third, the enzyme is protected from inhibitions
by carbamate by binding of a competitive inhibitor such
as trifluoroacetophenone (TFA). The Ki step leads to the
tetrahedral intermediate and the k2 step leads to the car-
bamyl enzyme intermediate. Moreover, values of Ki and k2
can be calculated from Equation 1 [16-29]:
kapp = k2 [I]/(Ki(1+ [S]/Km)+ [I]) (1)
In Equation 1, kapp values are first-order rate constants
which can be obtained as described in Hosie et al. [17].
Bimolecular rate constant, ki = k2/Ki, is related to overall
inhibitory potency.
Results
For the first time, we synthesize four optical pure diaster-
eomers of 1. (1R, αR)-1, (1R, αS)-1, (1S,αR)-1, and (1S,
αS)-1 (Figure 2) are synthesized from the condensation of
R-(+)- or S-(-)-1, 1'-bi-2-naphthanol with R-(+)- or S-(-)-
α-methylbenzyl isocyanate in the presence of a catalytic
amount of pyridine in CH2Cl2. The [α]25 
Dvalues for (1R,
αR)-1, (1R, αS)-1, (1S,αR)-1, and (1S, αS)-1 are +40, +21,
-21, and -41°, respectively.
Like most carbamates, the four diastereomers of 1  are
characterized as the pseudo substrate inhibitors of CEase
(Figures 3 and 4) and meet some of the criteria proposed
by Abeles and Maycock [38]. When CEase is incubatedBMC Biochemistry 2005, 6:17 http://www.biomedcentral.com/1471-2091/6/17
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with a carbamate in the presence of TFA (2 µM), a known
competitive inhibitor of CEase [22] before the inhibition
reaction, the enzyme is protected from inhibition by car-
bamate by binding of TFA as described in Hosie et al. [17]
(Figure 4B).
The inhibition data for CEase by the four diastereomers of
1 and the two enantiomers of 2 are summarized (Table 1).
The stereochemical preference of CEase for the binaphthyl
moiety of 1 (R > S, ca. 10 times) is the same as that for 2
[20,22]. The stereoselectivity of CEase for the α-methyl-
benzyl moiety of 1 is also the R-form (2–3 times over S-
form).
Among the four diastereomers of 1, (1R, αR)-1 is the most
potent inhibitor and its overall inhibitory potency (ki) is
about the same as that of R-2 (Table 1). On the other
hand, (1S, αS)-1 is the least potent inhibitor of CEase and
its overall inhibitory potency is about 17-fold lower than
that of S-2. All k2 values for the CEase inhibition by1 are
about the same (Table 1).
Discussion
According to the X-ray crystal structure, CEase-catalyzed
hydrolysis of cholesteryl linoleate has been proposed (Fig-
ure 1) [30,31]. Like most carbamates, the four diastereom-
ers of 1  are characterized as the pseudo substrate
inhibitors of CEase (Figures 3 and 4) [16-29] and meet
some of the criteria proposed by Abeles and Maycock
[38]. Therefore, the CEase inhibition by the four diastere-
omers of 1is proposed (Figure 5) [4]. In this mechanism,
the α-methylbenzylcarbamyl moiety of 1 is proposed to
bind to ABS of the enzyme, and the binaphthyl moiety of
1 is proposed to bind to LBS of the enzyme. The stereo-
chemical preference of CEase for the binaphthyl moiety of
1 (1R > 1S in Table 1) at LBS of the enzyme is therefore
identical to that of 2 (R > S) due to the fact that the nucle-
ophilic attack of the Ser194 of the enzyme to the carbonyl
group of the inhibitor sterically hinder from one of the
naphthyl group of the inhibitors (Figure 5A) [20,22].
Since 4-nitrophenyl-N-benzyl-carbamate is a very potent
pseudo substrate inhibitor of CEase [21,25,26], the ben-
zylcarbamyl moiety of the inhibitor is believed to bind
Possible interactions for cholesteryl linoleate in the active site of CEase [30,31] Figure 1
Possible interactions for cholesteryl linoleate in the active site of CEase [30,31].
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Structures of the four diastereomers of carbamates 1 and the two atropisomers of 2 Figure 2
Structures of the four diastereomers of carbamates 1 and the two atropisomers of 2.
O
HO N
H
O
H3C H
O
OH
N
H
O
H3C H
(1R, DR)-1 R
(1S, DR)-1 S
R
R O
HO N
H
O
H CH3
(1R, DS)-1
R
S
O
OH
N
H
O
H CH3
(1S, DS)-1
S
S
O
OH
N
H
O
(S)-2
S
O
HO N
H
O
(R)-2
RBMC Biochemistry 2005, 6:17 http://www.biomedcentral.com/1471-2091/6/17
Page 5 of 9
(page number not for citation purposes)
tightly to ABS of the enzyme. Similarly, the α-methylben-
zylcarbamyl moiety of 1 is also believed to bind to ABS of
the enzyme. The stereochemical preference of CEase for
the α-methylbenzylcarbamyl moiety of 1 at ABS of the
enzyme is also R > S (αR > αS in Table 1). The possible rea-
son for this is the fact that one of the naphthyl group and
the α-methyl group of (1S, αS)-1 are located at the same
side of the nucleophilic attack of Ser194 when the inhibi-
tor binds to CEase and therefore these two groups of the
inhibitor sterically hinder the nucleophilic attack of
Ser194 to the inhibitor (Figure 5A). On the other hand,
(1R, αR)-1 does not have any hindrance for the nucle-
ophilic attack of Ser194 (Figure 5B) and therefore (1R,
αR)-1 is the most potent inhibitor among the four diaster-
eomers of 1 (Table 1).
The stereoselectivity of CEase at ABS of the enzyme for the
α-methylbenzyl group of 1 (R > S) (Table 1) is the same
as that of CRL at its ABS for 2-methyl-6-(2-thienyl) hex-
anate [39]. For the Ki step (Figure 3), (1R, αR)-1 and (1S,
αR)-1 bind to CEase 2.5 and 3 times more tightly than
(1R, αS)-1 and (1S, αS)-1, respectively. The Ki value with
regard to the chiral center at the α-position of 1 is quite
low compared to that with regard to the binaphthol chiral
axis of 1 (Table 1) [20,22] and to that with regard to the
phosphorus chiral center of isomalathion [13]. Therefore,
we propose that ABS of CEase does not show high selec-
tivity for the chiral acyl group due to a narrow and hydro-
phobic binding pocket for ABS [30,31], which selectively
and tightly binds to the benzyl phenyl moiety of the
inhibitor and results in the discrimination of stereoselec-
tivity by either the hydrogen atom or the methyl group at
the α-position of the four diastereomers of 1 (Figure 5).
(1R, αR)-1 and (1R, αS)-1 are bound to CEase 10 and 12
times more tightly than (1S, αR)-1 and (1S, αS)-1, respec-
tively (Table 1); however, R-2 is bound to CEase only 1.6
times more tightly than S-2 [20,22]. The possible reason
is that the binding of the phenyl moiety of the α-methyl-
benzylcarbamyl group of 1 to ABS (Figure 5) constrains
the binaphthol moiety of 1 to a more favorable conforma-
tion to bind with LBS, on the other hand, the n-butyl car-
bamyl of 2  has lots of room to "breathe" in ABS and
Kinetic scheme for the pseudo substrate inhibition of CEase Figure 3
Kinetic scheme for the pseudo substrate inhibition of CEase.
E + I
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EI
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P
EI'
A: The kapp vs. [I] plot for inhibition of the CEase-catalyzed  hydrolysis of PNPB by (1R, α R)-1 Figure 4
A: The kapp vs. [I] plot for inhibition of the CEase-catalyzed 
hydrolysis of PNPB by (1R, αR)-1. [PNPB] = 50 µM. The 
solid line is a least-squares fit to Eq. (1) [17]; the parameters 
of the fit are Ki = 0.27 ± 0.01 µM and k2 = (2.0 ± 0.2) × 10-3 s-
1. B: % activity of CEase vs. the time period for inhibition of 
the enzyme with (1R, αR)-1 (50 nM) in the absence and pres-
ence of TFA (2 µM). [PNPB] = 50 µM. All the procedures fol-
lowed those of Hosie et al. [17]. For the control experiments 
(squares), CEase was incubated alone at 25.0°C for a period 
of time before the inhibition reaction (CEase + PNPB + (1R, 
αR)-1). For the carbamate inhibition experiments (triangles), 
CEase was incubated with (1R, αR)-1 (50 nM) at 25.0°C for a 
period of time before the enzyme reaction (CEase + PNPB). 
For the protection experiments (circles), CEase was incu-
bated with (1R, αR)-1 (50 nM) and TFA (2 µM) at 25.0°C for 
a period of time before the enzyme reaction (CEase + 
PNPB).BMC Biochemistry 2005, 6:17 http://www.biomedcentral.com/1471-2091/6/17
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therefore the binaphthol moiety of2 has many conforma-
tions and results in loosely binding to LBS.
The k2 values for the four diastereomers of 1 are about the
same. This means that the k2 step is insensitive to the ster-
eochemistry of 1. In other words, the stereoselectivity of
CEase for (1R, αR)-1 primarily results from the Ki step.
The  k2 values for all diastereomers of1  are lower than
those for the two atropisomers of 2 (Table 1). The possi-
ble reason is that the n-butylcarbamyl enzyme from both
atropisomers of 2 is relatively more stable than the α-
methylbenzylcarbamyl enzymes from the four diastere-
omers of 1.
Overall, we report that CEase has two stereoselective bind-
ing sites at LBS and ABS for the four diastereomers of 1.
CEase [13], Chromobacterium viscosum lipase, and Rhizopus
oryzal lipase [40] also show two stereoselective binding
sites at LBS and ES for organic phosphorus compounds.
Therefore, it is possible that CEase and lipase may contain
totally three stereoselective binding sites at ABS, ES, and
LBS for the six diastereomers of substrates or inhibitors.
Conclusion
Four diastereomers of 1 are synthesized and characterized
as the pseudo substrate inhibitors of pancreatic choles-
terol esterase. The inhibitory potencies for these four dias-
tereomeric inhibitors are in the descending order of (1R,
αR)-1, (1R, αS)-1, (1S, αR)-1, and (1S, αS)-1. The enzyme
stereospecificity toward the 1, 1'-bi-2-naphthyl moiety of
the inhibitors is the R-form and is the same as that for 2.
The enzyme stereospecificity toward the α-methylbenzyl-
carbamyl moiety of the inhibitors is also R-form. For the
first time, we observe that the acyl binding site of choles-
terol esterase shows stereospecificity for diastereomeric
inhibitors.
Methods
Materials
Porcine pancreatic CEase (ca. 70% pure since the
observed Km value for this enzyme catalyzed hydrolysis of
PNPB is 1.4 times higher than that for the pure enzyme
[17]) and PNPB were obtained from Sigma; TFA and other
chemicals were obtained from Aldrich. Silica gel used in
liquid chromatography (Licorpre Silica 60, 200–400
mesh), medium pressure liquid chromatography column
(LiChroprep Si 60) and thin layer chromatography plates
(Kieselgel 60 F254) were obtained from Merck. An UV
lamp as well as an UV detector (Linear UV-106 or ISCO
UA-6) was used in detection. Hexane-ethyl acetate solvent
gradient was used in liquid chromatography and medium
pressure liquid chromatography. Other chemicals were of
the highest quality available commercially. Carbamates 2
were synthesized as described before [20,22].
Instrumental methods
1H and 13C NMR spectra were recorded at 300 and 75.4
MHz (Varian-VXR 300 spectrometer), respectively. The 1H
and  13C NMR chemical shifts were referred to internal
Me4Si. UV spectra were recorded on an UV-visible spectro-
photometer (Hewlett Packard 8452A or Beckman DU-
650) with a cell holder circulated with a water bath. High
resolution mass spectra were recorded at 70 eV on a Joel
JMS-SX/SX-102A mass spectrophotometer. Elemental
analyses were preformed on a Heraeus instrument.
Synthesis of four diastereomers of 1
(1R, αR)-1, (1R, αS)-1, (1S, αR)-1, and (1S, αS)-1 (Figure
2) were prepared from the condensation of R-(+)- or S-(-
)-α-methylbenzyl isocyanate ([α]20 
D = +10° or -10°) with
1 equivalent of R-(+)- or S-(-)-1, 1'-bi-2-naphthol ([α]20 
D
= +34° or -34°) in the presence of a catalytic amount of
pyridine in CH2Cl2 at 25°C for 24 h (80–95 % yield). All
products were purified by liquid chromatography or
medium pressure liquid chromatography (silica gel, hex-
ane-ethyl acetate) and characterized by 1H and 13C NMR
spectra and high resolution mass spectra.
(1R, αR)-1, (1R, αS)-1, (1S, αR)-1, and (1S, αS)-1:  1H
NMR (CDCl3, 300 MHz) δ/ppm 1.02 (d, J = 6.6 Hz, 3H,
CH(Ph)CH3), 4.48 (quintet, J = 7 Hz, 1H, CH(Ph)CH3),
5.27 (d, J = 8.1 Hz, 1H, NH), 7.07–8.06 (m, 17H,
Table 1: Inhibition constants for CEase-catalyzed hydrolysis of PNPB in the presence of the four diastereomers of 1 and the two 
enantiomers of 2
Inhibitor Ki(µM) k2(10-3s-1)k i(103 M-1s-1)
(1R, αR)-1 0.20 ± 0.01 2.0 ± 0.2 10 ± 1
(1R, gαS)-1 0.50 ± 0.03 2.0 ± 0.2 4.0 ± 0.4
(1S, gαR)-1 2.0 ± 0.1 2.0 ± 0.2 1.0 ± 0.1
(1S, gαS)-1 6.0 ± 0.4 1.8 ± 0.2 0.30 ± 0.03
(R)-2a 0.8 ± 0.1 10 ± 1 12 ± 2
(S)-2a 1.3 ± 0.1 6.0 ± 0.5 5.0 ± 0.6
aTaken from references [20,22].BMC Biochemistry 2005, 6:17 http://www.biomedcentral.com/1471-2091/6/17
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Possible interactions between the stereoisomers of 1 and CEase [31,31] Figure 5
Possible interactions between the stereoisomers of 1 and CEase [31,31]. (A) CEase and (1S, αS)-1. The methyl benzyl moiety 
of the inhibitor binds to ABS of the enzyme. Three unfavorable repulsions (in red) from the methyl moiety and Ser194, the 
naphthyl moiety and Ser194, and the naphthyl moiety and His435 hinder the nucleophilic attack of Ser194 to the carbonyl 
group of the inhibitor. (B) CEase and (1R, αR)-1. There is no unfavorable repulsion for the nucleophilic attack of Ser194 to the 
carbonyl group of the inhibitor.
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aromatic H); 13C NMR (CDCl3, 75.4 MHz) δ/ppm 21.88
(CH3), 50.36 (CH(Ph)CH3), 122.45, 123.51, 125.43,
125.69, 126.08, 126.48, 126.60, 127.10, 127.24, 127.91,
128.18, 128.37, 128.53, 129.40, 131.40, 133.30, 133.41,
142.98, and 147.20 (aromatic Cs), 153.91 (C = O); High
resolution mass spectra: Found: 433.1674; C29H23NO3
requires 433.1678. [α]25 
D = +40, +21, -21, and -41° for
(1R, αR)-1, (1R, αS)-1, (1S, αR)-1, and (1S, αS)-1, respec-
tively. The stability of these compounds is very high at -
20°C (no significant change for the optical rotation in 1
month).
Enzyme kinetics and data reduction
All kinetic data were obtained by using an UV-visible spec-
trophotometer that was interfaced to a computer. Micro-
cal Origin (version 6.0) was used for all least squares curve
fittings. The CEase inhibition was assayed as described in
Hosie et al. [17]. The temperature was maintained at
25.0°C by a refrigerated circulating water bath. All reac-
tions were performed in sodium phosphate buffer (pH
7.0) containing NaCl (0.1 M), acetonitrile (2% by vol-
ume), substrate PNPB (50 µM), triton X-100 (0.5 % by
weight) and varying concentration of inhibitors (from 0.1
to 10 µM). The Km value for CEase-catalyzed hydrolysis of
PNPB was calculated to be 140 ± 10 µM from the Michae-
lis-Menten equation. Requisite volumes of stock solution
of substrate and inhibitors in acetonitrile were injected
into reaction buffers via a pipet. CEase was dissolved in
sodium phosphate buffer (0.1 M, pH 7.0). Reactions were
initiated by injecting enzyme and monitored at 410 nm
on the UV-visible spectrometer. First-order rate constants
(the kapp values) for inhibition of CEase were determined
as described by Hosie et al. [17] Values of Ki and k2 can be
obtained by the parameters of non-linear least squares
curve fittings of kapp vs. [I] plot to Equation (1) (Figure
4A). Duplicate sets of data were collected for each inhibi-
tor concentration.
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